newsfilter
← Latest News
Business Wire·

enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones

Michael Heffernan assumes the role of Chairman of the Board Dr. Richard Glickman to step down Pre-Biologics License Application (BLA) meeting with the FDA planned for 2H 2026 Initiation of BLA submission for